Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China ; volume:10 ; number:1 ; day:8 ; month:4 ; year:2024 ; pages:1-11 ; date:12.2024
Future Journal of Pharmaceutical Sciences ; 10, Heft 1 (8.4.2024), 1-11, 12.2024
- Creator
-
Sampene, Agyemang Kwasi
Nyirenda, Fatuma
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43094-024-00632-2
- URN
-
urn:nbn:de:101:1-2406210856184.904481581924
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
30.01.2050, 11:21 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sampene, Agyemang Kwasi
- Nyirenda, Fatuma
- SpringerLink (Online service)
Other Objects (12)
Evaluating the US pharmaceutical patent policy
Pharmaceutical biotechnology : drug discovery and clinical applications
Data-driven discovery of growth fields : evaluating opportunities in collaboration and new product development
Defining Patient Centric Pharmaceutical Drug Product Design
Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Advertising regulations in pharmaceutical markets: Product versus enlightenment
Transparent computational intelligence models for pharmaceutical tableting process
Correction to: Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Should product-specific advertisement be regulated in pharmaceutical markets?
Key considerations for successful biotechnological and pharmaceutical product launches
Product Category Rules (PCR) for pharmaceutical products and processes
Evaluating the impact of Brexit on the pharmaceutical industry
Evaluating the US pharmaceutical patent policy
Pharmaceutical biotechnology : drug discovery and clinical applications
Data-driven discovery of growth fields : evaluating opportunities in collaboration and new product development
Defining Patient Centric Pharmaceutical Drug Product Design
Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Advertising regulations in pharmaceutical markets: Product versus enlightenment
Transparent computational intelligence models for pharmaceutical tableting process
Correction to: Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Should product-specific advertisement be regulated in pharmaceutical markets?
Key considerations for successful biotechnological and pharmaceutical product launches
Product Category Rules (PCR) for pharmaceutical products and processes
Evaluating the impact of Brexit on the pharmaceutical industry
Evaluating the US pharmaceutical patent policy
Pharmaceutical biotechnology : drug discovery and clinical applications
Data-driven discovery of growth fields : evaluating opportunities in collaboration and new product development
Defining Patient Centric Pharmaceutical Drug Product Design
Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Advertising regulations in pharmaceutical markets: Product versus enlightenment
Transparent computational intelligence models for pharmaceutical tableting process
Correction to: Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Should product-specific advertisement be regulated in pharmaceutical markets?
Key considerations for successful biotechnological and pharmaceutical product launches
Product Category Rules (PCR) for pharmaceutical products and processes